UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023646 |
|---|---|
| Receipt number | R000026587 |
| Scientific Title | A phase II study evaluating immune-priming effect of Nivolumab in combination with palliative radiationtherapy in previously treated patients with non-small cell lung cancer. |
| Date of disclosure of the study information | 2016/08/16 |
| Last modified on | 2019/08/20 16:24:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/08/16 21:02:25 | ||
| 2 | Update | 2016/08/17 22:11:43 | Organization Organization Category of Funding Organization |
|
| 3 | Update | 2016/11/19 15:22:38 | Last name of lead principal investigator Last name of lead principal investigator |
|
| 4 | Update | 2019/02/18 10:05:24 | Recruitment status Last follow-up date |
|
| 5 | Update | 2019/08/20 16:19:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Institute Institute Department Tel1 Email1 Organization Organization Address Address Tel |
|
| 6 | Update | 2019/08/20 16:20:14 | Number of participants that the trial has enrolled |
|
| 7 | Update | 2019/08/20 16:24:11 | Date of IRB |
